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recall subjects. Most subjects were willing to pay extra to
have dental gel available, both for themselves and for
others, at amounts far exceeding the projected acquisi-
tion price.
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Willingness-to-pay (WTP) provides a method of valuing
diverse outcomes of therapy in monetary units. The
methodology is based on informed individual’s willing-
ness to make trade-offs between health and a wide range
of commodities. OBJECTIVES: To determine the WTP
for weight-loss with two new weight reduction therapies,
orlistat (13.4 lbs) and sibutramine (12–14 lbs) in a Cana-
dian population. METHODS: WTP was assessed in 97
volunteers between the ages of 20 and 64 using contin-
gent valuation. Respondents were randomly assigned to
one of two bid strategies with randomly chosen starting
points. Demographic characteristics (i.e., age, sex, house-
hold income, education, smoking, height, weight, health-
related quality of life (EuroQol), and previous attempts
at weight-loss) were elicited using a standardized ques-
tionnaire. Main effects were tested by ANCOVA control-
ling for age, gender, education, income, smoking, and
obesity (Body Mass Index  30 kg/m2). RESULTS: Re-
spondents had a mean age of 34.6  10.6 years, were
predominantly female (64.6%), and had a mean EuroQol
score of 80.1  15.9 (out of 100). Only 22.7% of the re-
spondents were obese, however 61.9% reported having
tried to lose weight. Respondents stated that they would
be willing to pay an average of 13%  1.3% of their
monthly household income for orlistat and 11.1% 
1.3% for sibutramine (CDN$521 (95% CI: $450–$593)
vs. CDN$446 (95% CI: $375–$518) respectively; F 
0.0805, P  0.371) each month for a period of two years
(CDN$1  US$0.673). Estimates from respondents in
older age groups (P  0.001) and higher income levels (p 
0.001) were significantly associated with higher WTP
values. CONCLUSION: Individuals in Ontario, Canada
place a high value on pharmacologic therapies for weight
reduction.
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Diabetes is known to cause workforce exit after compli-
cations develop, yet little research has examined the ef-
fects of the disease and its treatment on work efficiency
while diabetics are employed. OBJECTIVE: The goal of
this research is to determine whether or not diabetes is
associated with lower levels of work productivity. METH-
ODS: To measure work productivity, a survey was de-
signed to collect data on work efficiency, as defined by
Osterhaus, et al. and van Roijen, et al. The survey also
included items about absences, work history, workforce
exit, job satisfaction, income, demographics and health
care utilization. The survey was administered to diabetic
and non-diabetic people who were employed. RESULTS:
On average, the 72 diabetics who completed the survey
reported significantly lower work productivity than their
362 non-diabetic co-workers. Diabetics averaged the
equivalent of seven hours of lost work time per month
while non-diabetics lost only four hours per month (P 
0.03). Surprisingly, the cost of these productivity losses
was not significantly different between diabetics and
non-diabetics. This is because the diabetics reported in-
comes that averaged $10,000 less per year than their
non-diabetic co-workers (P  0.02). CONCLUSIONS:
Diabetics appear to be less productive at work than their
non-diabetic peers, on average. The cost of lower produc-
tivity appears to be borne, at least in part, by the workers
themselves, who earn significantly less than their non-di-
abetic co-workers, on average. Given the rising preva-
lence of diabetes and variations in treatment patterns, the
effects of diabetes treatments on work productivity and
career progression deserves consideration.
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In Singapore, provision of pharmaceutical care by com-
munity pharmacists is not widely practiced. However,
two patient care centers were established in 1998 by a re-
tail pharmacy chain to provide a range of specialized
pharmaceutical care services. OBJECTIVES: This study
aimed to investigate the feasibility of having such services
in Singapore by (1) characterizing the customers utilizing
the pharmaceutical care services offered to identify a tar-
get group most likely to benefit from such services, and
(2) assessing customers’ perception and acceptance of the
services, as well as their willingness to pay for these ser-
vices. METHODS: A questionnaire was constructed to
evaluate the perception and acceptance of customers uti-
lizing the pharmaceutical care services. The questionnaire
was administered by a face-to-face interview. Qualitative
analysis of the responses was performed and where ap-
propriate, statistical analyses including ANOVA and un-
paired t-test were performed. RESULTS: Seventeen cus-
tomers completed the survey, representing 0.26% of the
